RYCBX | RYUCX | RYCBX / RYUCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 24 years | - |
Gain YTD | -32.945 | -15.987 | 206% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | 1000 | 1000 | 100% |
Net Assets | 9.32M | 33.4M | 28% |
Annual Yield % from dividends | 4.79 | 3.88 | 124% |
Returns for 1 year | -39.87 | -20.07 | 199% |
Returns for 3 years | -44.86 | -19.34 | 232% |
Returns for 5 years | -84.96 | -55.48 | 153% |
Returns for 10 years | -95.82 | -75.83 | 126% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VILSX | 41.70 | 0.24 | +0.58% |
Value Line Select Growth Institutional | |||
SCMGX | 32.87 | 0.14 | +0.43% |
Sands Capital Global Growth Inst | |||
RCGHX | 17.05 | -0.06 | -0.35% |
Virtus KAR Health Sciences C | |||
MGPSX | 81.93 | -0.50 | -0.61% |
ProFunds Mid Cap Growth Svc | |||
JCNNX | 32.27 | -0.30 | -0.92% |
Janus Henderson Contrarian N |